AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28333351 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (dosage not specified) administered from day 0 to day 14
Number of subjects: 48
Study 26393396 — intervention group
Group type: EXPERIMENTAL
Intervention: FSA‐NPS DI (dietary index)
Number of subjects: 6435
Study 26393396 — intervention group
Group type: EXPERIMENTAL
Intervention: FSA‐NPS DI in subjects with moderate energy intake (≤median)
Number of subjects: 6435
Study 26393396 — intervention group
Group type: EXPERIMENTAL
Intervention: FSA‐NPS DI in subjects with higher energy intake
Number of subjects: 6435
Study 26393396 — intervention group
Group type: EXPERIMENTAL
Intervention: FSA‐NPS DI and breast cancer risk
Number of subjects: 6435
Study 26393396 — intervention group
Group type: EXPERIMENTAL
Intervention: FSA‐NPS DI and prostate cancer risk
Number of subjects: 6435
Study 24268209 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin (0.75 mg/kg bolus followed by 1.75 mg/kg/hour infusion for ≥30 minutes prior to PCI and continued for ≥4 hours at 0.25 mg/kg/hour)
Number of subjects: 2200
Study 24268209 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care anticoagulation (heparins at guideline-recommended doses, with or without glycoprotein IIb/IIIa inhibitors)
Number of subjects: 2200
Study 21251384 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=41) - near- and middle-vision activities less than 30 hrs/week, more outdoor activities than 14-15 hrs/week
Number of subjects: 80
Study 21251384 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=39) - standard activities without specified restrictions
Number of subjects: 80
Study 21251384 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=41)
Number of subjects: 80
Study 21251384 — intervention group
Group type: EXPERIMENTAL
Intervention: All children in the study
Number of subjects: 80
Study 21251384 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=39)
Number of subjects: 80
Study 19118789 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive static stretching (SS)
Number of subjects: 28
Study 19118789 — intervention group
Group type: EXPERIMENTAL
Intervention: Contract-relax PNF (CRPNF) stretching
Number of subjects: 28
Study 19118789 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercises)
Number of subjects: 28
Study 19118789 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive static stretching (SS) and Contract-relax PNF (CRPNF) stretching
Number of subjects: 28
Study 17965934 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected relaxing music
Number of subjects: 56
Study 17965934 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical music
Number of subjects: 56
Study 17965934 — intervention group
Group type: COMPARATOR
Intervention: Heavy metal music
Number of subjects: 56
Study 17965934 — intervention group
Group type: COMPARATOR
Intervention: Silence
Number of subjects: 56
Study 15467626 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional suprahyoid neck dissection (FSHD)
Number of subjects: 36
Study 15467626 — intervention group
Group type: COMPARATOR
Intervention: Classical suprahyoid neck dissection (CSHD)
Number of subjects: 36
Study 15377585 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG power spectral frequencies from >35 Hz up to 127 Hz
Number of subjects: 39
Study 15377585 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequencies (<15 Hz)
Number of subjects: 39
Study 15377585 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequencies (>26 Hz)
Number of subjects: 39
Study 15377585 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency band between 15 and 26 Hz
Number of subjects: 39
Study 15377585 — intervention group
Group type: EXPERIMENTAL
Intervention: Power-line frequency (50 Hz) and its harmonics, 78 Hz
Number of subjects: 39
Study 9895019 — intervention group
Group type: EXPERIMENTAL
Intervention: Glu/Ex
Number of subjects: 6
Study 9895019 — intervention group
Group type: COMPARATOR
Intervention: No Glu/Ex
Number of subjects: 6
Study 7717498 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lignocaine gel
Number of subjects: 84
Study 7717498 — intervention group
Group type: COMPARATOR
Intervention: Lubafax gel (Control)
Number of subjects: 84
Study 2030413 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular instruction
Number of subjects: 49
Study 2030413 — intervention group
Group type: COMPARATOR
Intervention: Didactic instruction
Number of subjects: 49
Study 7225490 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes-open rotational vestibular stimulation
Number of subjects: 18
Study 7225490 — intervention group
Group type: COMPARATOR
Intervention: Control contact
Number of subjects: 18
Study 30577714 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention (FAN program)
Number of subjects: 54
Study 30577714 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention (control)
Number of subjects: 54
Study 28573499 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin
Number of subjects: 0
Study 28573499 — intervention group
Group type: COMPARATOR
Intervention: Standard/low-dose statins
Number of subjects: 0
Study 28573499 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 0
Study 26954484 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged Garlic Extract (AGE) 1200 mg daily for 4 weeks
Number of subjects: 26
Study 26954484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 25084009 — intervention group
Group type: EXPERIMENTAL
Intervention: ice‐slush with menthol
Number of subjects: 12
Study 25084009 — intervention group
Group type: EXPERIMENTAL
Intervention: cold with menthol
Number of subjects: 12
Study 25084009 — intervention group
Group type: COMPARATOR
Intervention: neutral with menthol
Number of subjects: 12
Study 23083313 — intervention group
Group type: EXPERIMENTAL
Intervention: $5 incentive
Number of subjects: 0
Study 23083313 — intervention group
Group type: COMPARATOR
Intervention: No incentive
Number of subjects: 0
Study 18839306 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese acupuncture
Number of subjects: 59
Study 18839306 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 59
Study 17616771 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg Salacia oblonga extract
Number of subjects: 66
Study 17616771 — intervention group
Group type: EXPERIMENTAL
Intervention: 480 mg Salacia oblonga extract
Number of subjects: 66
Study 17616771 — intervention group
Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 66
Study 15078396 — intervention group
Group type: EXPERIMENTAL
Intervention: PACs triggering AF
Number of subjects: 108
Study 15078396 — intervention group
Group type: COMPARATOR
Intervention: PACs not triggering AF
Number of subjects: 108
Study 15078396 — intervention group
Group type: COMPARATOR
Intervention: PACs in healthy controls
Number of subjects: 108
Study 12503274 — intervention group
Group type: EXPERIMENTAL
Intervention: Losec, 40 mg (omeprazole)
Number of subjects: 25
Study 12503274 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine, 80 mg (Quamatel)
Number of subjects: 25
Study 12503274 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphalugel
Number of subjects: 25
Study 12503274 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 25
Study 9793352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural analgesia with 75 mg of bupivacaine 0.50% administered through a peridural catheter at 8-hour intervals for up to three times
Number of subjects: 50
Study 7543323 — intervention group
Group type: EXPERIMENTAL
Intervention: Interstitial laser coagulation (ILC or LITT; laser‐induced interstitial thermotherapy)
Number of subjects: 239
Study 31997577 — intervention group
Group type: COMPARATOR
Intervention: Control condition (CONT): seated for 1 hour at a relative humidity (RH) of 40%
Number of subjects: 12
Study 31997577 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry condition (DRY): seated for 1 hour at a RH of 20%
Number of subjects: 12
Study 31997577 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise condition (EXER): seated for 40 minutes followed by 20 minutes of cycling exercise at a RH of 20%
Number of subjects: 12
Study 30942010 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative electroacupuncture intervention at Baliao point 30 min before PPH
Number of subjects: 60
Study 30942010 — intervention group
Group type: COMPARATOR
Intervention: Simple operation group (control)
Number of subjects: 60
Study 28625445 — intervention group
Group type: EXPERIMENTAL
Intervention: Pecs block with levobupivacaine 0.25%
Number of subjects: 140
Study 28625445 — intervention group
Group type: COMPARATOR
Intervention: Placebo block with saline
Number of subjects: 140
Study 25611228 — intervention group
Group type: EXPERIMENTAL
Intervention: pemetrexed-carboplatin-bevacizumab
Number of subjects: 939
Study 25611228 — intervention group
Group type: COMPARATOR
Intervention: paclitaxel-carboplatin-bevacizumab
Number of subjects: 939
Study 23138261 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 0.5 mg
Number of subjects: 8
Study 23138261 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 1 mg
Number of subjects: 8
Study 23138261 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 3 mg
Number of subjects: 8
Study 20642580 — intervention group
Group type: EXPERIMENTAL
Intervention: CLA 4.5 g/day
Number of subjects: 28
Study 20642580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 17419879 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterol esters (PSE) in capsule form (1.3 grams of PSE/day)
Number of subjects: 16
Study 17419879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 16299195 — intervention group
Group type: EXPERIMENTAL
Intervention: Trendelenburg tilt at 10 degrees
Number of subjects: 20
Study 16299195 — intervention group
Group type: COMPARATOR
Intervention: Trendelenburg tilt at angles greater than 10 degrees (15, 20, 25, and 30 degrees)
Number of subjects: 20
Study 16299195 — intervention group
Group type: EXPERIMENTAL
Intervention: Trendelenburg tilt cumulative effects
Number of subjects: 20
Study 12117878 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity (body mass index > or = 30 kg/m(2))
Number of subjects: 89835
Study 12117878 — intervention group
Group type: COMPARATOR
Intervention: Control (postmenopausal women)
Number of subjects: 89835
Study 12117878 — intervention group
Group type: COMPARATOR
Intervention: Entire cohort (all women)
Number of subjects: 89835
Study 10430341 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic variceal banding ligation (EVL)
Number of subjects: 100
Study 10430341 — intervention group
Group type: COMPARATOR
Intervention: Sclerotherapy (EVS)
Number of subjects: 100
Study 9419519 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiral CT with 150 ml diatrizoate meglumine
Number of subjects: 131
Study 9419519 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiral CT with 75 ml diatrizoate meglumine
Number of subjects: 131
Study 9419519 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiral CT with 100 ml diatrizoate meglumine
Number of subjects: 131
Study 9419519 — intervention group
Group type: COMPARATOR
Intervention: Dynamic CT with 150 ml diatrizoate meglumine
Number of subjects: 131
Study 2098573 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 100 mg twice a day for three months
Number of subjects: 4
Study 2098573 — intervention group
Group type: COMPARATOR
Intervention: No flurbiprofen (control)
Number of subjects: 4
Study 7024383 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP by face-mask for 4 hours after surgery
Number of subjects: 24
Study 7024383 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CPAP)
Number of subjects: 24
Study 30718622 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin exercise (5 × 60 min/weekly for 12 weeks)
Number of subjects: 170
Study 30718622 — intervention group
Group type: COMPARATOR
Intervention: Control group (unaltered lifestyle during 12 weeks)
Number of subjects: 170
Study 28716081 — intervention group
Group type: EXPERIMENTAL
Intervention: Telenursing (TN)
Number of subjects: 0
Study 28716081 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 0
Study 25646406 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (70μg/2800 IU cholecalciferol daily for 52 weeks)
Number of subjects: 46
Study 25646406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 25646406 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical cure (parathyroidectomy)
Number of subjects: 46
Study 24421408 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbed sutures (V‐Loc, Covidien)
Number of subjects: 229
Study 24421408 — intervention group
Group type: COMPARATOR
Intervention: Smooth absorbable sutures (control)
Number of subjects: 229
Study 24421408 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid-absorbing barbed suture
Number of subjects: 229
Study 24421408 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-absorbing barbed suture
Number of subjects: 229
Study 21879101 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular coffee (130 mg caffeine)
Number of subjects: 12
Study 21879101 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-espresso coffee
Number of subjects: 12
Study 21879101 — intervention group
Group type: EXPERIMENTAL
Intervention: Encapsulated caffeine (134 mg)
Number of subjects: 12
Study 21879101 — intervention group
Group type: COMPARATOR
Intervention: Placebo-control capsule
Number of subjects: 12
Study 19643497 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspheric intraocular lens (SN60WF, Alcon)
Number of subjects: 26
Study 19643497 — intervention group
Group type: COMPARATOR
Intervention: Spherical intraocular lens (SN60AT, Alcon)
Number of subjects: 26
Study 17365766 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-generated practice feedback
Number of subjects: 19
Study 17365766 — intervention group
Group type: COMPARATOR
Intervention: No feedback (control)
Number of subjects: 19
Study 15716246 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention (medical, physiotherapy, and occupational therapy)
Number of subjects: 313
Study 15716246 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 313
Study 15716246 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention
Number of subjects: 313
Study 12377836 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited sleep‐recording device (home study) with technician setup (group 1)
Number of subjects: 55
Study 12377836 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited sleep‐recording device (home study) with patient's own setup (group 2)
Number of subjects: 55
Study 12377836 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited sleep‐recording device (home study)
Number of subjects: 55
Study 12377836 — intervention group
Group type: COMPARATOR
Intervention: Limited sleep‐recording device vs. polysomnography
Number of subjects: 55
Study 12377836 — intervention group
Group type: COMPARATOR
Intervention: Home study-derived parameters
Number of subjects: 55
Study 12377836 — intervention group
Group type: EXPERIMENTAL
Intervention: Home sleep studies
Number of subjects: 55
Study 9787982 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine eye drops
Number of subjects: 113
Study 9787982 — intervention group
Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 113
Study 9787982 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocabastine eye drops
Number of subjects: 113
Study 7540938 — intervention group
Group type: EXPERIMENTAL
Intervention: New screening technologies
Number of subjects: 0
Study 7540938 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening approaches
Number of subjects: 0
Study 2692792 — intervention group
Group type: EXPERIMENTAL
Intervention: Off‐Axis photoscreener
Number of subjects: 236
Study 2692792 — intervention group
Group type: EXPERIMENTAL
Intervention: Otago photoscreener
Number of subjects: 236
Study 2692792 — intervention group
Group type: EXPERIMENTAL
Intervention: Off‐Axis photoscreener (younger children 24 months or less)
Number of subjects: 236
Study 2692792 — intervention group
Group type: EXPERIMENTAL
Intervention: Otago photoscreener (younger children 24 months or less)
Number of subjects: 236
Study 2692792 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques with pupil dilated
Number of subjects: 236
Study 336175 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincristine, dactinomycin, and cyclophosphamide (VAC) for 2 years
Number of subjects: 423
Study 336175 — intervention group
Group type: COMPARATOR
Intervention: Vincristine plus dactinomycin for 1 year with postoperative irradiation
Number of subjects: 423
Study 336175 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive 'pulse' VAC or 'pulse' VAC plus Adriamycin with radiation after 6 weeks
Number of subjects: 423
Study 336175 — intervention group
Group type: COMPARATOR
Intervention: Intensive 'pulse' VAC or 'pulse' VAC plus Adriamycin
Number of subjects: 423
Study 31852579 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month oxaliplatin and 5-fluorouracil or oxaliplatin and capecitabine
Number of subjects: 6088
Study 31852579 — intervention group
Group type: COMPARATOR
Intervention: 6-month oxaliplatin and 5-fluorouracil or oxaliplatin and capecitabine
Number of subjects: 6088
Study 31852579 — intervention group
Group type: COMPARATOR
Intervention: 6-month treatment
Number of subjects: 6088
Study 31852579 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month treatment
Number of subjects: 6088
Study 30250407 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental occupational therapy (OT) intervention
Number of subjects: 40
Study 30250407 — intervention group
Group type: COMPARATOR
Intervention: Standard care (task‐oriented rehabilitation)
Number of subjects: 40
Study 26865854 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT 160 mg + LPV/r
Number of subjects: 20
Study 26865854 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT 320 mg + LPV/r
Number of subjects: 20
Study 24881208 — intervention group
Group type: EXPERIMENTAL
Intervention: Presurgical nasoalveolar molding (PNAM) treatment prior to operation in group A
Number of subjects: 57
Study 24881208 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated) in group B
Number of subjects: 57
Study 24881208 — intervention group
Group type: COMPARATOR
Intervention: Control group (normally developed nose and lip palate infants) in group C
Number of subjects: 57
Study 22228415 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA/Aza
Number of subjects: 289
Study 22228415 — intervention group
Group type: EXPERIMENTAL
Intervention: Tac/MMF
Number of subjects: 289
Study 19158589 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer
Number of subjects: 80
Study 19158589 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity diary
Number of subjects: 80
Study 19158589 — intervention group
Group type: COMPARATOR
Intervention: Pedometer and Activity diary comparison
Number of subjects: 80
Study 17134960 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat (120 mg three times a day) combined with diet
Number of subjects: 139
Study 17134960 — intervention group
Group type: COMPARATOR
Intervention: Diet only
Number of subjects: 139
Study 16260202 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound (TVU)
Number of subjects: 39115
Study 16260202 — intervention group
Group type: EXPERIMENTAL
Intervention: CA‐125
Number of subjects: 39115
Study 16260202 — intervention group
Group type: EXPERIMENTAL
Intervention: Both tests (TVU and CA‐125)
Number of subjects: 39115
Study 16260202 — intervention group
Group type: EXPERIMENTAL
Intervention: TVU
Number of subjects: 39115
Study 16260202 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening
Number of subjects: 39115
Study 11868008 — intervention group
Group type: EXPERIMENTAL
Intervention: Tannenbaum stent
Number of subjects: 106
Study 11868008 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene stent
Number of subjects: 106
Study 10506815 — intervention group
Group type: EXPERIMENTAL
Intervention: KeraVision Intacs
Number of subjects: 95
Study 7603372 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammographic screening
Number of subjects: 160000
Study 7603372 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mammographic screening)
Number of subjects: 160000
Study 2088995 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral controlled-release morphine (MS Contin Tablets; MSC)
Number of subjects: 70
Study 2088995 — intervention group
Group type: COMPARATOR
Intervention: Previous analgesic regimens
Number of subjects: 70
Study 7206385 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress condition (S group) with negative and stressful comments
Number of subjects: 30
Study 7206385 — intervention group
Group type: COMPARATOR
Intervention: Nonstress condition (NS group) with positive and comfortable comments
Number of subjects: 30
Study 31813658 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate sodium (PPS) monotherapy for 16 weeks
Number of subjects: 26
Study 31813658 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 26
Study 31813658 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate sodium (PPS) monotherapy
Number of subjects: 26
Study 28560502 — intervention group
Group type: EXPERIMENTAL
Intervention: Infiltration treatment
Number of subjects: 22
Study 28560502 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 22
Study 27604241 — intervention group
Group type: EXPERIMENTAL
Intervention: DMPA
Number of subjects: 53
Study 27604241 — intervention group
Group type: COMPARATOR
Intervention: Copper IUD
Number of subjects: 53
Study 24912053 — intervention group
Group type: EXPERIMENTAL
Intervention: Strawberry consumption (500 g daily for 30 days)
Number of subjects: 31
Study 24912053 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 subjects)
Number of subjects: 31
Study 22360383 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (thrice daily for 4 weeks)
Number of subjects: 10
Study 20105143 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment during infancy and childhood
Number of subjects: 37
Study 20105143 — intervention group
Group type: COMPARATOR
Intervention: Control group (no GH treatment)
Number of subjects: 37
Study 18767582 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Zhongji (CV 3), Shuidao (ST 28), Tainshu (ST 25), Qugu (CV 2), Zigong (EX-CA 1)
Number of subjects: 66